CurrentEndo
Get Weekly

Topic · page 4 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 121–160 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Insulin Resistance–Adiposity Burden and Incident Cardiovascular Disease Across Glycaemic Transitions in Prediabetes: Risk Stratification After Reversion to Normoglycaemia

    Cohort study

  2. Diabetes Res Clin Pract

    Risk of incident diabetes after initiation of 5α-reductase inhibitor plus α-blocker combination therapy: A nationwide cohort study with age-specific analyses

    Cohort study

  3. Cardiovasc Diabetol

    Excess risk of cardiovascular disease and mortality after amputation in type 2 diabetes: a nationwide population study from the Swedish National Diabetes Register

    Cohort study

  4. Diabetes Care

    A Randomized Placebo-Controlled Trial of HTD1801 Monotherapy in Participants With Type 2 Diabetes

    Randomized controlled trial

  5. Cardiovasc Diabetol

    Triglyceride-glucose waist-to-height ratio in relation to prevalent and incident multimorbidity: cross-sectional and prospective evidence from four national studies

    Cross-sectional study

  6. Diabetes Obes Metab

    Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study

    Research article

  7. Diabetologia

    Divergent complication patterns of type 2 diabetes in African individuals who are lean versus overweight or obese: a multi-cohort analysis

    Cross-sectional study

  8. Diabetes Obes Metab

    Ten‐Year Cost‐Effectiveness of the Risk Assessment and Management Programme—Diabetes Mellitus ( RAMP ‐ DM ) Relative to Usual Care in Hong Kong Public Primary Care: A Population‐Based Cohort Study

    Cohort study

  9. Diabetes Obes Metab

    Variation in Treatment Patterns of Type 2 Diabetes in Older Patients

    Cohort study

  10. Diabetes Res Clin Pract

    Red blood cells in prediabetes: Early alterations, progressive trajectories, and clinical potential

    Mechanistic study

  11. Diabetes Res Clin Pract

    BMI trajectories and their relation to medication, comorbidities, and healthcare service use among people with type 2 diabetes mellitus

    Cohort study

  12. Diabetes Res Clin Pract

    Optimal dose and exercise modality to improve HbA1c in older adults with type 2 diabetes mellitus: a systematic review with pairwise, network, and dose–response meta-analyses

    Meta-analysis

  13. Diabetes Care

    Cardiometabolic Effects of Dual GLP-1 and Glucagon Receptor Agonists: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    Meta-analysis

  14. Diabetes Res Clin Pract

    Trends and disparities in population-based cerebrovascular disease–related mortality involving diabetes in the United States (1999–2023) and forecasts to 2035: a CDC WONDER analysis

    Cross-sectional study

  15. Diabetes Care

    Waist Circumference, Relative Fat Mass Index, and BMI as Classifiers of Diabetes Status: A Comparative, Cross-sectional Analysis in 82 Low- and Middle-Income Countries

    Cross-sectional study

  16. Diabetes Res Clin Pract

    Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium–glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity

    Cohort study

  17. Diabetologia

    Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA)

    Randomized controlled trial

  18. BMJ Open Diabetes Res Care

    Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review

    Meta-analysis

  19. Obesity (Silver Spring)

    Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes

    Cohort study

  20. Diabet Med

    The effect of telemonitoring on quality of life in people with insulin‐treated type 2 diabetes: A secondary analysis of a randomised controlled trial

    Secondary analysis

  21. Diabetes Res Clin Pract

    Neuromuscular electrical stimulation protocols for glycaemic control in adults with type 2 diabetes mellitus: a systematic review

    Meta-analysis

  22. J Diabetes Sci Technol

    Non-Invasive Glucose Monitoring Using mμSORS: A Population-Based Validation Study Across Diverse Patient Variability

    Diagnostic or prognostic study

  23. JAMA

    Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes

    Randomized controlled trial

  24. Eur J Endocrinol

    SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalization, and mortality

    Research article

  25. Diabetes Res Clin Pract

    Trends in the association between diabetes duration and cardiovascular events: a population-based cohort study

    Cohort study

  26. Lancet Diabetes Endocrinol

    Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial

    Randomized controlled trial

  27. Diabetes Res Clin Pract

    Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes

    Cohort study

  28. BMJ Open Diabetes Res Care

    Cardiometabolic factors and risk of dementia in people with type 2 diabetes in England: a large retrospective cohort study

    Cohort study

  29. Diabetes Obes Metab

    Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction‐Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open‐Label Trial

    Randomized controlled trial

  30. Diabetes Obes Metab

    Fatty Liver Index and Differential Glycemic Responses to Ipragliflozin Versus Sitagliptin Over 52 Weeks: An Exploratory Post Hoc Analysis of the Niigata Ipragliflozin and Sitagliptin With Metformin (N‐ ISM ) Study

    Secondary analysis

  31. Diabetes Obes Metab

    Association of Lipid Ratios With Cardiovascular Outcomes in Type 2 Diabetes: A Population Cohort Study

    Cohort study

  32. Diabetes Obes Metab

    Body Composition Remodelling During GLP ‐1‐Based Therapy: A Systematic Review and Meta‐Analysis Using a Hierarchical Physiological Framework

    Meta-analysis

  33. J Clin Endocrinol Metab

    Helicobacter pylori infection and insulin resistance in a screening population: frequentist and Bayesian analyses

    Cross-sectional study

  34. Diabetes Obes Metab

    Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium‐Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

    Cohort study

  35. Diabetes Obes Metab

    Vegetable‐First Meal Sequence Suppresses Postprandial Glycaemic Excursions and Variability in Young Women With High‐Risk Phenotype for Early‐Onset Type 2 Diabetes: A 4‐Arm Randomized Crossover Trial With Continuous Glucose Monitoring

    Randomized controlled trial

  36. Diabetes Obes Metab

    When Metabolically Healthy Is Not Low Risk: BMI Thresholds for Incident Diabetes in East Asian Adults

    Cohort study

  37. Diabetes Res Clin Pract

    The landscape of monogenic diabetes in Italy. Comparisons with other European countries

    Cohort study

  38. Diabetes Res Clin Pract

    Country-specific burden of type 2 diabetes mellitus in the Caribbean, 1990–2023: Insights from the global burden of disease study

    Secondary analysis

  39. Diabetologia

    Diminished arginine bioavailability during hyperglycaemia distinguishes individuals with A−β+ ketosis-prone diabetes from those with type 2 diabetes: implications for the pathogenesis of ketoacidosis in A−β+ ketosis-prone diabetes

    Mechanistic study

  40. Lancet Diabetes Endocrinol

    Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial

    Randomized controlled trial

All 4,758 Briefs in ExploreShowing Briefs 121–160 of 4,758, newest first